Search Results 141-150 of 17319 for ulcerative colitis

  1. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC). Print details.

  2. Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents - Mayo Clinic

    ... ulcerative colitis and Crohn's disease. "Although almost all patients with IBD mounted an antibody response, there was a decrease in antibody response in ...

  3. Pyoderma gangrenosum - Symptoms and causes - Mayo Clinic

    It's often seen in people who have autoimmune diseases, such as ulcerative colitis, Crohn's disease and arthritis. And some studies suggest that it may be ...

  4. Back to Her "New Normal" - Mayo Clinic News Network

    This time her testing was felt to be most suggestive of ulcerative colitis, not Crohn's disease, as the cause of Strom's condition. “For patients like Ann ...

  5. Mayo Clinic Minute: What is inflammatory bowel disease? Video Audio People often associate inflammatory bowel disease with t

    There are two main types of IBD: Crohn's disease and ulcerative colitis. Victor Chedid, M.D.. Gastroenterology. Mayo Clinic. "Ulcerative colitis only impacts ...

  6. Lifestyle and Diet in Inflammatory Bowel Disease - Mayo Clinic News Network

    Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...

  7. A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) · Overview.

  8. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  9. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  10. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...